Home
About
Company
Leadership team
Scientific team
Collaborations
Science
Platform
Publications
Applications
Drug Development
Patient Stratification
Multiple Sclerosis
Checkpoint Inhibition
Contact Us
CellPrint Biotechnology is advancing the discovery and development of novel drug therapies with its patented 
CellPrint™
 platform that provides single-cell resolution of molecular expression patterns and intermolecular relationships with unparalleled sensitivity and precision.

				Copyright © 2018 CellPrint Biotechnology, LLC.			
Home
About
Company
Leadership team
Scientific team
Collaborations
Science
Platform
Publications
Applications
Drug Development
Patient Stratification
Multiple Sclerosis
Checkpoint Inhibition
Contact Us